Dow Up 0.51% Nasdaq Up 0.24%

Corcept Therapeutics Incorporated (CORT)

-NasdaqCM
2.99 Down 0.04(1.32%) Nov 21, 4:00PM EST
Prev Close:3.03
Open:3.06
Bid:2.80 x 200
Ask:N/A
1y Target Est:3.25
Beta:2.55
Earnings Date:Jan 28 - Feb 2 (Est.)
Day's Range:2.98 - 3.12
52wk Range:1.69 - 4.49
Volume:167,552
Avg Vol (3m):182,242
Market Cap:302.56M
P/E (ttm):N/A
EPS (ttm):-0.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CORTDown 1.32%302.56M
AZNUp 0.47%94.17B
GSKUp 0.04%111.55B
NVSDown 0.30%229.73B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.33
Quarterly EPS Est (Dec-14) :-0.06
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):-0.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Corcept Therapeutics Incorporated, a pharmaceutical company, is engaged in the discovery, development, and commercialization of drugs for the treatment of metabolic, psychiatric, and oncologic disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback